Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-02-13 @ 3:42 AM
Study NCT ID:
NCT00486668
Status:
UNKNOWN
Last Update Posted:
2016-06-06
First Post:
2007-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
NSABP B-41
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |